Sun Pharma Advanced Research Company (SPARC) has entered into exclusive licenses with a subsidiary of China Medical System Holdings (CMS) to develop and commercialize multiple products in Mainland China, Hong Kong, Macao and Taiwan.

The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and may be further extended as per mutual agreement between the parties.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

127.05 -0.70 (-0.55%)
21-Jan-2026 09:07 View Price Chart
Peers
Company Name CMP
Syngene Internation. 604.60
Indegene 478.45
CMS Info Systems 325.05
Sagility 51.50
Smartworks Coworking 445.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×